Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 17 studies | 48% ± 16% | |
| peripheral blood | 17 studies | 30% ± 10% | |
| brain | 14 studies | 31% ± 13% | |
| intestine | 10 studies | 43% ± 20% | |
| kidney | 8 studies | 45% ± 13% | |
| eye | 8 studies | 38% ± 12% | |
| liver | 6 studies | 38% ± 20% | |
| adipose | 5 studies | 21% ± 5% | |
| lymph node | 5 studies | 41% ± 20% | |
| pancreas | 4 studies | 58% ± 15% | |
| bone marrow | 4 studies | 33% ± 19% | |
| uterus | 4 studies | 56% ± 15% | |
| breast | 4 studies | 46% ± 4% | |
| prostate | 4 studies | 30% ± 12% | |
| placenta | 3 studies | 78% ± 10% | |
| adrenal gland | 3 studies | 30% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6397.34 | 1445 / 1445 | 100% | 164.94 | 183 / 183 |
| kidney | 100% | 8464.04 | 89 / 89 | 100% | 155.32 | 901 / 901 |
| lung | 100% | 6893.60 | 578 / 578 | 100% | 178.62 | 1155 / 1155 |
| ovary | 100% | 8647.82 | 180 / 180 | 100% | 238.33 | 430 / 430 |
| prostate | 100% | 6808.42 | 245 / 245 | 100% | 207.94 | 502 / 502 |
| stomach | 100% | 5581.99 | 359 / 359 | 100% | 214.67 | 286 / 286 |
| thymus | 100% | 7757.64 | 653 / 653 | 100% | 298.25 | 605 / 605 |
| uterus | 100% | 7527.74 | 170 / 170 | 100% | 217.19 | 459 / 459 |
| brain | 100% | 7333.75 | 2638 / 2642 | 100% | 170.29 | 705 / 705 |
| intestine | 100% | 6683.37 | 966 / 966 | 100% | 246.80 | 526 / 527 |
| skin | 100% | 8022.30 | 1809 / 1809 | 100% | 177.55 | 471 / 472 |
| pancreas | 100% | 4126.03 | 327 / 328 | 100% | 176.86 | 178 / 178 |
| liver | 100% | 3556.35 | 225 / 226 | 100% | 137.41 | 406 / 406 |
| breast | 100% | 7617.82 | 459 / 459 | 99% | 165.63 | 1112 / 1118 |
| bladder | 100% | 6771.62 | 21 / 21 | 99% | 211.19 | 500 / 504 |
| adrenal gland | 100% | 7472.07 | 258 / 258 | 99% | 167.56 | 228 / 230 |
| adipose | 100% | 7653.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 230.46 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 269.16 | 29 / 29 |
| spleen | 100% | 6781.16 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 178.28 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 179.57 | 1 / 1 |
| blood vessel | 100% | 7286.46 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 2832.67 | 841 / 861 | 0% | 0 | 0 / 0 |
| muscle | 95% | 2290.25 | 763 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 88% | 3746.02 | 820 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_0051301 | Biological process | cell division |
| GO_0048268 | Biological process | clathrin coat assembly |
| GO_0072583 | Biological process | clathrin-dependent endocytosis |
| GO_0030125 | Cellular component | clathrin vesicle coat |
| GO_0099631 | Cellular component | postsynaptic endocytic zone cytoplasmic component |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0016020 | Cellular component | membrane |
| GO_0030118 | Cellular component | clathrin coat |
| GO_0030672 | Cellular component | synaptic vesicle membrane |
| GO_0071439 | Cellular component | clathrin complex |
| GO_0032588 | Cellular component | trans-Golgi network membrane |
| GO_0036020 | Cellular component | endolysosome membrane |
| GO_0030130 | Cellular component | clathrin coat of trans-Golgi network vesicle |
| GO_0098835 | Cellular component | presynaptic endocytic zone membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0030132 | Cellular component | clathrin coat of coated pit |
| GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
| GO_0005819 | Cellular component | spindle |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0042277 | Molecular function | peptide binding |
| GO_0032050 | Molecular function | clathrin heavy chain binding |
| GO_0051020 | Molecular function | GTPase binding |
| GO_0005198 | Molecular function | structural molecule activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | CLTA |
| Protein name | Clathrin light chain A (Lca) Clathrin light chain A Clathrin light chain |
| Synonyms | |
| Description | FUNCTION: Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Acts as a component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge . . FUNCTION: Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. . FUNCTION: Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. . |
| Accessions | P09496 ENST00000396603.6 [P09496-3] F8WF69 ENST00000464497.5 ENST00000470744.5 [P09496-4] ENST00000242285.11 [P09496-1] ENST00000345519.10 [P09496-2] S4R3F6 ENST00000493185.2 ENST00000466396.6 C9J8P9 ENST00000540080.5 [P09496-5] |